Medication info
Sitagliptin Tablet 25 mg (Sitagliptin Hydrochloride Hydrate)

Sitagliptin Tablet 25 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.35mg / 1 tablet
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
Pink, round, biconvex film-coated tablets
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202005197 · Approved 2020.07.20 · Insurance code 628901860

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medication is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, reduction of the sulfonylurea or insulin dose may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dose adjustment according to renal function is required, assessment of renal function is recommended before and periodically after starting this medication. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in Type 2 diabetes patients
View approved original text

This medication is used to improve blood sugar control in patients with Type 2 diabetes by complementing dietary and exercise therapy. It can be used alone, but if there has been no prior treatment experience with diabetes medications or blood sugar control is difficult with monotherapy, it can be combined with metformin. Additionally, in cases where sufficient blood sugar control is not achieved with monotherapy or combination therapy of sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be added to effectively manage blood sugar. This systematically improves blood sugar control and assists in diabetes management.

How to take

Adult dose

This medication is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, reduction of the sulfonylurea or insulin dose may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dose adjustment according to renal function is required, assessment of renal function is recommended before and periodically after starting this medication. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered regardless of the timing of dialysis.

Precautions

This medication may cause allergic reactions; if symptoms such as skin rash, difficulty breathing, swelling of the face or neck occur, cease use immediately and consult a physician. Acute pancreatitis, a serious pancreatic inflammation, may occur, so if symptoms such as abdominal pain, vomiting, or loss of appetite appear during use, inform healthcare personnel immediately. It should not be used in patients with Type 1 diabetes or diabetic ketoacidosis, and it should be avoided in patients with allergy to this medication or its components. Patients with impaired kidney function may have increased drug concentrations; therefore, dosage adjustments should be made according to a physician's instructions, and regular kidney function tests are important. When administering this medication, the risk of hypoglycemia may increase; thus, if taken with other hypoglycemic agents like insulin or sulfonylureas, blood sugar changes should be carefully monitored. If symptoms such as severe joint pain or formation of blisters on the skin occur, consult a physician immediately to determine whether to discontinue the medication. Women who are pregnant or breastfeeding are not recommended to use this medication, and safety and efficacy have not been established in children or adolescents under 18 years of age. Elderly patients are at higher risk for impaired kidney function, so kidney function should be periodically examined before and after taking this medication, and dosage should be carefully adjusted. In case of overdose, removal of the drug from the gastrointestinal tract and monitoring of overall health status, including heart condition, are necessary; if needed, some drugs can be removed via hemodialysis. No significant drug interactions have been reported when this medication is used in conjunction with other specific drugs; however, careful monitoring is necessary if digoxin is being taken.

Side effects

  • Severe hypersensitivity reaction
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
  • diarrhea
Show 32 more
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe arthralgia with disability
  • blistering pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • elevated liver enzymes
  • acute renal failure
  • peripheral edema
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • increased serum triglycerides
  • elevated low-density lipoprotein
  • hyperglycemia
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent exposure to air or moisture and keep it at room temperature between 1°C and 30°C. Proper storage will help maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Pink, round, biconvex film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.